Morgan Stanley Oramed Pharmaceuticals Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Morgan Stanley holds 32,095 shares of ORMP stock, worth $74,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,095

Previous 35,825 10.41%

Holding current value

$74,460

Previous $76,000 5.26%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$2.03 - $2.38 $7,571 - $8,877	-3,730 Reduced 10.41%	32,095 $72,000
Q1 2025 May 15, 2025	BUY	$2.0 - $2.62 $2,384 - $3,123	1,192 Added 3.44%	35,825 $76,000
Q4 2024 Feb 14, 2025	SELL	$2.17 - $2.52 $21,743 - $25,250	-10,020 Reduced 22.44%	34,633 $83,000
Q3 2024 May 14, 2025	SELL	$2.21 - $2.63 $1,726 - $2,054	-781 Reduced 1.72%	44,653 $108,000
Q3 2024 Nov 14, 2024	SELL	$2.21 - $2.63 $1,726 - $2,054	-781 Reduced 1.72%	44,653 $108,000
Q2 2024 May 14, 2025	BUY	$2.07 - $2.83 $22,358 - $30,566	10,801 Added 31.19%	45,434 $116,000
Q2 2024 Oct 17, 2024	BUY	$2.07 - $2.83 $1,500 - $2,051	725 Added 1.62%	45,434 $116,000
Q2 2024 Aug 14, 2024	BUY	$2.07 - $2.83 $1,500 - $2,051	725 Added 1.62%	45,434 $116,000
Q1 2024 Oct 17, 2024	SELL	$2.18 - $3.58 $1,580 - $2,595	-725 Reduced 1.6%	44,709 $130,000
Q1 2024 Aug 16, 2024	SELL	$2.18 - $3.58 $42,581 - $69,928	-19,533 Reduced 30.41%	44,709 $130,000
Q1 2024 May 15, 2024	SELL	$2.18 - $3.58 $42,581 - $69,928	-19,533 Reduced 30.41%	44,709 $130,000
Q4 2023 Aug 16, 2024	BUY	$1.71 - $2.57 $32,161 - $48,336	18,808 Added 41.4%	64,242 $148,000
Q4 2023 Feb 13, 2024	BUY	$1.71 - $2.57 $6,374 - $9,580	3,728 Added 6.16%	64,242 $148,000
Q3 2023 Nov 15, 2023	BUY	$2.51 - $3.55 $41,977 - $59,370	16,724 Added 38.19%	60,514 $157,000
Q2 2023 Aug 14, 2023	SELL	$2.12 - $4.47 $509,533 - $1.07 Million	-240,346 Reduced 84.59%	43,790 $156,000
Q1 2023 May 15, 2023	SELL	$1.93 - $13.1 $62,252 - $422,540	-32,255 Reduced 10.19%	284,136 $619,000
Q4 2022 Feb 14, 2023	SELL	$5.88 - $12.03 $1.24 Million - $2.53 Million	-210,715 Reduced 39.98%	316,391 $3.81 Million
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $734,827 - $1.58 Million	-159,745 Reduced 23.26%	527,106 $3.42 Million
Q2 2022 Oct 27, 2022	BUY	$3.72 - $9.0 $345,301 - $835,407	92,823 Added 15.63%	686,851 $3.15 Million
Q2 2022 Aug 15, 2022	BUY	$3.72 - $9.0 $345,301 - $835,407	92,823 Added 15.63%	686,851 $3.15 Million
Q1 2022 Oct 27, 2022	SELL	$8.19 - $13.89 $760,220 - $1.29 Million	-92,823 Reduced 13.51%	594,028 $5.14 Million
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $1.7 Million - $2.88 Million	207,408 Added 53.65%	594,028 $5.14 Million
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $3.46 Million - $7.93 Million	266,615 Added 222.17%	386,620 $5.52 Million
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $1.46 Million - $2.86 Million	120,005 New	120,005 $2.64 Million

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.7M

Call Options Held

46.2K

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.1M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account